logo
  

Dollar General Introduces Spendwell Banking Platform

Dollar General (DG) announced a series of new financial services including spendwell banking platform, a buy-now, pay-later test program with Sezzle and new FIS Worldpay card reward points payment option.

Through a partnership with InComm Payments, and issued by MetaBank, the spendwell Bank Account and Visa debit card is now available at Dollar General's stores, and through a dedicated online platform and mobile banking app. Spendwell will provide customers with two financial account options including one with no monthly fees and another that allows customers to earn 1% unlimited cash back to be redeemed on purchases at Dollar General.

Dollar General also plans to launch a test of a buy-now, pay-later purchase option through a new partnership with Sezzle at more than 1,700 stores in Texas. The DG Buy Now Pay Later program will provide customers with zero-interest payments on purchases, allowing them to pay for their purchases in four installments.

With FIS' Premium Payback, a real-time rewards redemption network, Dollar General customers will have an option to redeem eligible credit and debit card rewards
points toward their DG purchase. It is currently available at more than 18,000 DG stores in 46 states.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT